Dual-Tox DPO

NuMedica

$29.90
(No reviews yet) Write a Review
SKU:
NM-NM532-1
Availability:
Allow 5 to 7 business days for delivery
Minimum Purchase:
1 unit
Already Registered?
How to Gain Access to Store?

Dual-Tox DPO by NuMedica

Dual-Tox DPO by NuMedica is designed to support balanced activity of the body s Phase I and Phase II detoxification processes. It has been formulated to contain select ingredients, Dual Phase Optimizers (DPO), to enhance the activities of hepatic detoxification enzymes and support healthy detoxification pathways. The 5-MTHF in this formula Quatrefolic® is the most biologically active form of folate, allowing rapid uptake into the bloodstream. The 5-MTHF in this formula is also known as the "L" form of 5-MTHF since it is the reduced form of folate. *
 
- Dual Phase Optimizers to Support Phase I & II Detox*
 
Recommendation:
NuMedica suggests taking four capsules per day or as directed by your healthcare practitioner.
 
Serving size: 4 Capsules
Servings per container: 15 or 30
 
Amount per serving: 
Vitamin B6 (as pyridoxal-5'-phosphate) 50 mg
Folate 800 mcg
  Provided As:
5-MTHF (6S-5-methyltetrahydrofolic acid, glucosamine salt) 400 mcg
Folinic Acid 400 mcg
Vitamin B12 (as methylcobalamin) 200 mcg
Artichoke (Cynara scolymus) (leaf) extract (10:1) 600 mg
Watercress (Rorippa nasturtium-aquaticum) (aerial) extract (4:1) 500 mg
Milk Thistle (Silybum marianum) (seed) extract (80% silymarin) 312 mg
Pomegranate (Punica granatum) (hull) extract (40% ellagic acid) 250 mg
Alpha-lipoic Acid 200 mg
Green Tea (Camellia sinensis) (leaf) extract 200 mg
  (95% polyphenols, 45% EGCG, 75% catechins)
N-Acetyl L-Cysteine (NAC) 200 mg
Sodium Sulphate 200 mg
Calcium D-Glucarate 100 mg
Methylsulfonylmethane (MSM) 100 mg
 
Other Ingredients: Hydroxypropyl methylcellulose (vegetable capsule), rice flour, ascorbyl palmitate, microcrystalline cellulose, silica.
 
Does Not Contain: Milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, soy. 
 
As Quatrefolic® 5-MTHF. Quatrefolic® is a registered trademark of Gnosis S.p.A. Patent number 7,947,662.